0001214659-13-000795.txt : 20130214 0001214659-13-000795.hdr.sgml : 20130214 20130214080818 ACCESSION NUMBER: 0001214659-13-000795 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130214 DATE AS OF CHANGE: 20130214 EFFECTIVENESS DATE: 20130214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001232621 IRS NUMBER: 461592449 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14822 FILM NUMBER: 13606329 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-200-3830 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 13F-HR 1 a21313013fhr.txt FOR THE CALENDAR YEAR ENDED DECEMBER 31, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2012 Check here if Amendment [ ]; Amendment Number: __ This Amendment (Check only one): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Tang Capital Management, LLC Address: 4747 Executive Drive, Suite 510, San Diego, CA 92121 Form 13F File Number: 28-14822 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Kevin C. Tang Title: Managing Director of Tang Capital Management, LLC Phone: 858-200-3830 Signature, Place, and Date of Signing: /s/ Kevin C. Tang San Diego, CA February 14, 2013 ----------------------- ------------------------ ------------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE REPORT SUMMARY: NUMBER OF OTHER INCLUDED MANAGERS: 1 FORM 13F INFORMATION TABLE ENTRY TOTAL: 35 FORM 13F INFORMATION TABLE VALUE TOTAL: 267,652 (thousands) LIST OF OTHER INCLUDED MANAGERS: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. 1 Kevin C. Tang 28-14818

FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE ACELRX PHARMACEUTICALS INC COM 00444T100 5,325 1,250,000 SH SOLE 1,250,000 0 0 AEGERION PHARMACEUTICALS INC COM 00767E102 9,499 374,260 SH SOLE 374,260 0 0 AFFYMAX INC COM 00826A109 9,238 486,463 SH SOLE 486,463 0 0 AMARIN CORP PLC COM 023111206 4,450 550,000 SH SOLE 550,000 0 0 ANTHERA PHARMACEUTICALS INC COM 03674U102 656 1,058,261 SH SOLE 1,058,261 0 0 BIOMARIN PHARMACEUTICAL INC NOTE 2.500% 3/29/13 09061GAC5 8,904 3,000,000 PRN SOLE 3,000,000 0 0 CELL THERAPEUTICS INC COM 150934883 390 300,000 SH SOLE 300,000 0 0 CYCLACEL PHARMACEUTICALS INC COM 23254L306 3,827 631,561 SH SOLE 631,561 0 0 DENDREON CORP COM 24823Q107 2,224 420,400 SH SOLE 420,400 0 0 DENDREON CORP COM 24823Q107 421 79,600 SH SHARED 1 0 79,600 -DEFINED DENDREON CORP NOTE 2.875% 1/15/16 24823QAC1 20,151 26,515,000 PRN SOLE 26,515,000 0 0 DEPOMED INC COM 249908104 13,228 2,137,056 SH SOLE 2,137,056 0 0 ENDOCYTE INC COM 29269A102 4,183 465,763 SH SOLE 465,763 0 0 HORIZON PHARMA INC COM 44047T109 806 346,129 SH SOLE 346,129 0 0 INTERMUNE INC COM 45884X103 2,907 300,000 SH SOLE 300,000 0 0 INTERMUNE INC NOTE 2.500% 9/15/18 45884XAE3 12,963 17,000,000 PRN SOLE 17,000,000 0 0 IRONWOOD PHARMACEUTICALS INC COM 46333X108 1,546 139,543 SH SOLE 139,543 0 0 MANNKIND CORP NOTE 3.750% 12/15/13 56400PAA0 29,564 41,494,000 PRN SOLE 41,494,000 0 0 MANNKIND CORP COM 56400P201 3,829 1,657,384 SH SOLE 1,657,384 0 0 MAP PHARMACEUTICALS INC COM 56509R108 1,565 100,000 SH SOLE 100,000 0 0 NAVIDEA BIOPHARMACEUTICALS INC COM 63937X103 3,591 1,269,079 SH SOLE 1,269,079 0 0 NEKTAR THERAPEUTICS COM 640268108 7,992 1,078,512 SH SOLE 1,078,512 0 0 ONCOGENEX PHARMACEUTICALS INC COM 68230A106 11,017 839,732 SH SOLE 839,732 0 0 ONCOTHYREON INC COM 682324108 2,851 1,484,980 SH SOLE 1,484,980 0 0 PACIRA PHARMACEUTICALS INC COM 695127100 177 10,151 SH SOLE 10,151 0 0 PDL BIOPHARMA INC COM 69329Y104 2,112 300,000 SH SOLE 300,000 0 0 PDL BIOPHARMA INC NOTE 2.875% 2/15/15 69329YAE4 49,246 37,474,000 PRN SOLE 37,474,000 0 0 QUESTCOR PHARMACEUTICALS INC COM 74835Y101 15,141 566,642 SH SOLE 566,642 0 0 SALIX PHARMACEUTICALS INC COM 795435106 12,142 300,000 SH SOLE 300,000 0 0 SAVIENT PHARMACEUTICALS INC NOTE 4.750% 1/31/18 80517QAA8 5,745 31,919,000 PRN SOLE 31,919,000 0 0 SAVIENT PHARMACEUTICALS INC COM 80517Q100 727 692,800 SH SOLE 692,800 0 0 SOMAXON PHARMACEUTICALS INC COM 834453201 839 275,079 SH SOLE 275,079 0 0 SPECTRUM PHARMACEUTICALS INC COM 84763A108 5,538 495,100 SH SOLE 495,100 0 0 THRESHOLD PHARMACEUTICALS INC COM 885807206 5,957 1,414,981 SH SOLE 1,414,981 0 0 VANDA PHARMACEUTICALS INC COM 921659108 8,901 2,405,661 SH SOLE 2,405,661 0 0